OnKure Therapeutics, Inc. Class A Common Stock (OKUR)

• Market cap: $38M
• 1 day: -0.35%
• 5 days: 2.55%
• 1 month: 23.25%
• 3 months: 24.34%
• 6 months: -42.89%
• Year to date: -67.02%
• 1 year: -82.87%
• 5 years: -97.98%
• 10 years: -97.98%
• Sector: Healthcare
• Industry: Biotechnology

About: OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.

Employees: 46

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

15% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 13

2% more funds holding

Funds holding: 47 [Q1] → 48 (+1) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 2 [Q1] → 2 (+0) [Q2]

9.65% less ownership

Funds ownership: 93.69% [Q1] → 84.04% (-9.65%) [Q2]

49% less capital invested

Capital invested by funds: $50.1M [Q1] → $25.8M (-$24.4M) [Q2]